Complement factor H-based assays for serum bactericidal activity against Neisseria meningitidis

Details for Australian Patent Application No. 2009288242 (hide)

Owner Children's Hospital & Research Center at Oakland The University of Massachussetts Novartis Vaccines & Diagnostics, Inc.

Inventors Granoff, Dan M.; Welsch, Jo Anne; Ram, Sanjay

Agent FB Rice

Pub. Number AU-A-2009288242

PCT Pub. Number WO2010/027872

Priority 61/092,356 27.08.08 US

Filing date 26 August 2009

Wipo publication date 11 March 2010

International Classifications

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

Event Publications

17 March 2011 PCT application entered the National Phase

  PCT publication WO2010/027872 Priority application(s): WO2010/027872

19 May 2011 Alteration of Name

  The name of the applicant has been altered to Novartis Vaccines and Diagnostics SRL; Children's Hospital & Research Center at Oakland; The University of Massachusetts

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009288245-Compounds that modulate intracellular calcium

2009288234-Chromatography membranes, devices containing them, and methods of use thereof